Luc Bracoud

Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial

Serge Gauthier, Howard Feldman, Lon S. Schneider et al. · The Lancet · 2016 · 405 citations · Full text

Neurodegenerative Diseases, Alzheimer's Disease, Pharmacology +10

Targeting Prodromal Alzheimer Disease With Avagacestat

Vladimir Coric, Stephen Salloway, Christopher H. van Dyck et al. · JAMA Neurology · 2015 · 229 citations · Full text

Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial

Gordon Wilcock, Serge Gauthier, Giovanni B. Frisoni et al. · Journal of Alzheimer s Disease · 2017 · 210 citations · Full text

Tissue Microstructural Changes Are Independently Associated With Cognitive Impairment in Cerebral Amyloid Angiopathy

Anand Viswanathan, Pratik Patel, Rosanna Rahman et al. · Stroke · 2008 · 79 citations · Full text

Whole‐body MRI with diffusion‐weighted sequences compared with 18 FDG PET‐CT, CT and superficial lymph node ultrasonography in the staging of advanced cutaneous melanoma: a prospective study

Jean-Christophe Jouvet, L. Thomas, Vivien Thomson et al. · Journal of the European Academy of Dermatology and Venereology · 2013 · 49 citations